Navigation Links
The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Date:2/25/2008

SAN DIEGO, Feb. 25 /PRNewswire/ -- Speid & Associates, a San Diego-based regulatory affairs and drug development consultancy, is hosting a six session Webinar series on diabetes and related metabolic diseases during the months of March and April. Speakers will include former Food and Drug Administration officials Dr. Alexander Fleming and Dr. Ray Lipicky, as well as a distinguished list of other guest speakers and panelists.

Researchers and companies involved in diabetes therapeutic development are finding a complex array of possible targets across diabetes (both type 1, type 2), the metabolic syndrome, and the complications and causes of diabetes. This translates into a complex pathway for therapeutic development and registration with many potential pitfalls along the way. The webinar series will promote discussion on the inter-related issues of diabetes/metabolic therapeutic development and registration.

Dr. Speid said, "I am delighted that the series will feature such a stellar list of speakers, to address these important topics and issues." Dr. Alexander Fleming, ex-FDA (formerly headed diabetes drug review) said, "There is no more active and controversial therapeutic development area than for diabetes drugs. I look forward to discussing the implications of the ACCORD trial and a number of other timely topics."

For many years, Dr. Ray Lipicky headed FDA's Division of Cardiorenal Drug Products. Among his many drug approvals was the first and essentially only approval of treatments for a diabetic complication. The participation of Drs. Lipicky and Fleming in this series mirrors the convergence of cardiovascular and metabolic therapeutics at multiple levels -- pathophysiology, drug targets, trial design, and clinical disciplines.

Speid & Associates, Inc. is a regulatory affairs and drug development consultancy based in San Diego, Calif. The firm, founded in 2004 by Dr. Lorna Speid, Ph.D., assists life science companies at various
'/>"/>

SOURCE Speid & Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related biology technology :

1. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
2. Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits
3. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
4. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
5. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
6. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
7. World Think Tank on Type 1 Diabetes Meets in Miami
8. New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays
9. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
10. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
11. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ire/ -- Myriant Technologies LLC ("Myriant"), a pr...f renewable bio-chemicals, Uhde Corporation of Am...mbH, one of the world,s leading engineering contra...the engineering, procurement & construction (E...ed on renewable feedstocks. The execution of this...
(Date:11/6/2009)...rstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDA...unced updated results from a Phase II study of int...astatic to the lung in a poster presentation at th...eeting held in Miami Beach, Florida, from November...Phase II Study of Intravenous REOLYSIN (Wild-type ...
(Date:11/5/2009)...ewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ...ird quarter ended September 30, 2009. GenVec repor...or the three months ended September 30, 2009 compa...) in the comparable quarter of 2008. For the nine ... was $14.1 million ($0.15 per share), compared to ...
(Date:11/5/2009)... ThermoGenesis Corp. (Na...oducts for processing and storing adult stem cells...fiscal 2010. ,, For the quarter ended September...illion, a 15 percent increase over revenues of $4....pany said the key contributors to the growth in re...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...c. (Amex:,ADL), developer and marketer of tests fo...diseases, announced today that it has conducted th...S private unit offering of,2,007,508 shares of com...s,of common stock, generating net proceeds of appr...ock were sold at $3.09 per share and the four year...
...,Pharmaceuticals, a division of Wyeth (NYSE: WYE ...ement claim for lost profits and other damages,aga... Teva,s launch of a,pantoprazole tablet -- a gener... disputed that its product infringes the United St... to Wyeth by Altana, recently,acquired by Nycomed,...
...ance in memory storage devices presents a new marv...ry small spaces. Considering the potential of nano... the University of California, Riverside, things a...the latest issue of Technology Review, Khizroev is... point to a future where a 10-terabit hard drive i...
Other Biology Technology:AMDL Announces Closing of Private Offering 2Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 3Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 4The Library of Congress in your wrist watch? 2
(Date:11/4/2009)..., NEW YORK, Oct. 27 Global Rainmak...y and advanced R&D laboratory, today announced...d is prepared to actively commercialize its suite ...biometric security offerings. ,, During the pas...ns of dollars to develop and deploy a series of co...
(Date:11/3/2009)..., BOCA RATON, FL (November 4, 2009) For more tha...the queen conch ( Strombus gigas ) have been unsuc...oprietary seeding techniques to produce beaded (nu...ueen conch have been developed by scientists from ...graphic Institute (HBOI). With less than two years...
(Date:11/3/2009)...,, WEST LAFAYETTE, Ind. - Chief executives i...d by about 129 times their "ideal salaries" in 200... proposed by a Purdue University researcher to det... pressing economic and corporate governance issues...for CEOs," said Venkat Venkatasubramanian, a profe...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4DuPont Adds Cotton to India Seed Product Lineup 12789 1DuPont Adds Cotton to India Seed Product Lineup 12789 2DuPont Adds Cotton to India Seed Product Lineup 12789 3DuPont Adds Cotton to India Seed Product Lineup 12789 4Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 1Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 2Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 4Nations first childrens hospital based safety store focuses on child injury prevention 50079 1Nations first childrens hospital based safety store focuses on child injury prevention 50079 2
... Researchers from the University of Minnesota Medi...polis VA Medical Center have identified a noninvas...eases. And its as simple as staring at a point of ...essful, painless, and objective diagnosis for brai...iveness of different treatments for these diseases...
... MADISON, WI, AUGUST 22, 2007- Climate change, a r...ns, and Earths surface; however, the study of anot...still very much underground. Few scientists are lo...limate change on groundwater systems. Little is kn...ater are responding to climate change. , Scientis...
... Miami, Fl (Aug 22, 2007) New research shows how ...daptations in order to transfer pollen on differen...lant species to share bats as pollinators. The st...nated flowers of the genus Burmeistera: analysis o...d in this weeks journal Proceedings of the Royal S...
Other Biology News:U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases 2Climate change goes underground 2Climate change goes underground 3How to share a bat 2
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
QCapture Pro Software from QImaging
Anti-XIAP Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-VEGF Receptor 2, phospho (Tyr1214) Polyclonal Antibody, Unconjugated from Abcam
Biology Products: